Advanced biliary tract cancer (BTC) includes cholangiocarcinoma, gallbladder carcinoma, and ampullary carcinoma. BTC is a ...

How would you summarize your study for a lay audience? Advanced biliary tract cancer (BTC) includes cholangiocarcinoma, gallbladder carcinoma, and ampullary carcinoma. BTC is a rare and aggressive ...

Compass Therapeutics' tovecimig shows promise in biliary cancer, boasting a 17.1% response rate. Despite high risks, I ...

How would you summarize your study for a lay audience?Advanced biliary tract cancer (BTC) includes cholangiocarcinoma, gallbladder carcinoma, and ...

Phase 3 results show the investigational drug norucholic acid is superior to placebo in halting disease progression.

Dr. Falk Pharma, a research-based pharmaceutical company specializing in digestive and metabolic medicine, today announced positive results from its pivotal, phase 3 trial (NUC-5) on norucholic acid ...